STING-targeted PET tracer for early assessment of tumor immunogenicity in colorectal cancer after chemotherapy.
Purpose: To optimize chemotherapy regimens and improve the effectiveness of chemotherapy combined with immunotherapy, a PET tracer specifically targeting the stimulator of interferon genes (STING), denoted as [18F]FBTA was used to monitor the early changes in tumor immunogenicity after chemotherapy...
| Published in: | European Journal of Nuclear Medicine & Molecular Imaging Vol. 51; no. 3; pp. 641 - 656 |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Journal Article |
| Published: |
Springer Nature
Feb2024
|
| Online Access: | View this record in EBSCOhost |